AGP Executive Report
Last update: 11 hours agoPrescribing Safety: A coroner in Jersey says prescribed cannabis contributed to David Morgan’s mental decline before his death in a flat fire. He has urged a pause on new prescriptions for mental-health conditions while tighter prescribing rules are developed. CBD and Sleep: An international review found too little reliable trial evidence to tell whether medical cannabis helps insomnia. Meanwhile, Australian biotech Avecho has restarted recruitment for its Phase III trial of a CBD sleep capsule after an interim analysis supported continuing the study; it hopes to develop an over-the-counter medicine. Patient Protections: New Zealand’s Cannabis Clinic is seeking clarity on proposed random drug tests for benefit claimants, warning that rules must account for people legally using prescribed medicinal cannabis.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.